SCHEMBL5804573

SCHEMBL5804573

CCCCCCCC1(O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O

nearest known ligand 0.41

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.37
PYGB P11216 2/20 0.36
PYGL P06737 1/20 0.36
PYGM P11217 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4557921 1.00 GAA (0.37) GAAPYGBPYGLPYGM
SCHEMBL1198926 1.00 GAA (0.37) GAAPYGBPYGLPYGM
SCHEMBL7560578 1.00 GAA (0.37) GAAPYGBPYGLPYGM
SCHEMBL9309793 1.00 GAA (0.37) GAAPYGBPYGLPYGM
SCHEMBL18527020 1.00 GAA (0.37) GAAPYGBPYGLPYGM
SCHEMBL25366499 1.00 GAA (0.37) GAAPYGBPYGLPYGM
SCHEMBL19326772 1.00 GAA (0.37) GAAPYGBPYGLPYGM
SCHEMBL9699503 1.00 GAA (0.37) GAAPYGBPYGLPYGM
SCHEMBL22409570 1.00 GAA (0.37) GAAPYGBPYGLPYGM
SCHEMBL9060748 1.00 GAA (0.37) GAAPYGBPYGLPYGM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3270887-B1 METHOD FOR PRODUCING AN EXTRACT OF A MATRIX OF VEGETABLE ORIGIN BY EXTRUSION WITH A HYDROTROPE SOLUTION FABRE PIERRE DERMO COSMETIQUE (FR) 2020-10-21 EP disclosed
EP-3270887-A1 METHOD FOR PRODUCING AN EXTRACT OF A MATRIX OF VEGETABLE ORIGIN BY EXTRUSION WITH A HYDROTROPE SOLUTION Pierre Fabre Dermo-Cosmétique (FR) 2018-01-24 EP disclosed
WO-2016146838-A1 METHOD FOR PRODUCING AN EXTRACT OF A MATRIX OF VEGETABLE ORIGIN BY EXTRUSION WITH A HYDROTROPE SOLUTION PIERRE FABRE DERMO-COSMETIQUE (FR) 2016-09-22 WO disclosed
US-8530463-B2 Multimodal particulate formulations HALE BIOPHARMA VENTURES LLC (US) 2013-09-10 US disclosed
WO-2006069098-A1 NANOPARTICULATE BICALUTAMIDE FORMULATIONS ELAN PHARMA INTERNATIONAL LTD. (IE) 2006-06-29 WO disclosed